Most Promising Technology prize for Enaam Chleilat

Congratulations to Enaam Chleilat for being awarded the Most Promising Technology prize at the MedFIT 2023 event in Strasbourg. This spotlight was for a newly patented, innovative dual-balloon & dual-flow catheter to prevent fatal arrhythmias in post-ischaemia reperfusion. This is a smarter, safer and versatile reperfusion approach compared to existing strategies. MedFIT is a leading medical technology European partnering event, that provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access. We wish Enaam and team (Callum Zgierski-Johnston and Peter Kohl) much success going from discovery to market.
[Press release MedFIT]